First Time Loading...

Samsung Biologics Co Ltd
KRX:207940

Watchlist Manager
Samsung Biologics Co Ltd Logo
Samsung Biologics Co Ltd
KRX:207940
Watchlist
Price: 745 000 KRW -1.32%
Updated: May 29, 2024

Samsung Biologics Co Ltd
Total Liabilities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Samsung Biologics Co Ltd
Total Liabilities Peer Comparison

Comparables:
P
087010
S
237690
F
220100
L
141080
C
268600

Competitive Total Liabilities Analysis
Latest Figures & CAGR of Competitors

Company Total Liabilities CAGR 3Y CAGR 5Y CAGR 10Y
Samsung Biologics Co Ltd
KRX:207940
Total Liabilities
₩6.5T
CAGR 3-Years
53%
CAGR 5-Years
30%
CAGR 10-Years
N/A
P
Peptron Inc
KOSDAQ:087010
Total Liabilities
₩15.3B
CAGR 3-Years
-28%
CAGR 5-Years
-11%
CAGR 10-Years
N/A
S
ST Pharm Co Ltd
KOSDAQ:237690
Total Liabilities
₩290.9B
CAGR 3-Years
23%
CAGR 5-Years
64%
CAGR 10-Years
N/A
F
FutureChem Co Ltd
KOSDAQ:220100
Total Liabilities
₩9.2B
CAGR 3-Years
-25%
CAGR 5-Years
-28%
CAGR 10-Years
N/A
L
LegoChem Biosciences Inc
KOSDAQ:141080
Total Liabilities
₩41.3B
CAGR 3-Years
20%
CAGR 5-Years
16%
CAGR 10-Years
23%
C
Cellivery Therapeutics Inc
KOSDAQ:268600
Total Liabilities
₩74B
CAGR 3-Years
175%
CAGR 5-Years
15%
CAGR 10-Years
N/A

See Also

What is Samsung Biologics Co Ltd's Total Liabilities?
Total Liabilities
6.5T KRW

Based on the financial report for Mar 31, 2024, Samsung Biologics Co Ltd's Total Liabilities amounts to 6.5T KRW.

What is Samsung Biologics Co Ltd's Total Liabilities growth rate?
Total Liabilities CAGR 5Y
30%

Over the last year, the Total Liabilities growth was -10%. The average annual Total Liabilities growth rates for Samsung Biologics Co Ltd have been 53% over the past three years , 30% over the past five years .